Cryptococcus gattii causes life-threatening yeast infection in the pulmonary and central nervous systems of humans and animals, and traditionally has been considered to restrict into the tropical and subtropical areas. Despite rare incidence of cryptococcosis caused by C. gattii in Korea, three strains of C. gattii isolated from cryptococcosis patients between 1993 and 2010 were identified. To determine the genetic diversity, 3 strains of C. gattii were typed using PCR fingerprinting with primer M13 and the restriction fragment length polymorphism (RFLP) of orotidine monophosphosphate pyrophosphorylase (URA5) gene. All isolates were identified as serotype B and MATα mating type. The molecular types of each strain, on the other hand, turned out to be distinct belonging to VGI, VGII or III types, respectively. Although the travel histories of the patients were not available, clinical C. gattii strains isolated in Korea may represent the diverse molecular types existing worldwide.
INTRODUCTION
Cryptococcosis is a life-threatening systemic fungal infection affecting healthy and immunocompromised hosts.
It is caused by two species of the genus Cryptococcus: C. neoformans and C. gattii (1) . Although both species cause either pulmonary or central nervous system infections, they differ in their ecology, epidemiology and clinical manifestations of disease (2, 3) . C. neoformans has been isolated worldwide, typically causing disease in immunocompromised hosts, especially AIDS patients. Currently, there are two variants of C. neoformans are recognized, C. neoformans var. grubii (serotype A), which is found worldwide, and C. neoformans var. neoformans (serotype D), which occurs mainly in Europe and South America (4, 5) . C. gattii, previously classified as C. neoformans var. gattii (serotypes B and C), was considered to be restricted to tropical and subtropical climates zones, and has been proposed to have a specific ecological association with a number of Eucalyptus species. Also this fungus has a predilection for infecting immunocompetent hosts (6, 7) . The relatively uncommon fungal pathogen C. gattii recently emerged as a significant cause of cryptococcal disease in human and animals from temperate regions in the Canada, United States, Europe and Asia (8~10).
The most recent classification of Cryptococcus species was established by molecular typing using PCR fingerprinting, random amplification of polymorphic DNA (RAPD), multilocus sequence typing (MLST) and amplified fragment length polymorphism (AFLP). Based on genetic differences, four distinct molecular types of C. neoformans (VNI to VNIV) and C. gattii (VGI to VGIV) have been recognized by various molecular typing methods (11, 12) .
These major genotypes differ in their epidemiology, virulence and geographic distribution. The molecular types VGI and VGII are prevalent worldwide and cause the majority of cases in healthy hosts. VGIII, which contains both serotypes B and C, has been isolated from America, Australasia, and Southern Asia, and VGIV, frequently associated with serotype C, is rare globally. VGIII and VGIV appear to more commonly infect immunocompromised patients, including those with AIDS similar to C. neoformans (11, 13, 14) . Although VGII is the genotype associated with outbreak in the British Columbia and Western North America, the most common genotype (in Australia and elsewhere) is VGI (9) . However, until now Korea has not been considered as C. gattii-endemic area.
C. gattii was isolated from many specimens from not only tropical and subtropical area, but also temperate region.
Based on those observations, we thought that ecological and environmental studies on C. gattii in Korea needed to determine reservoirs and to improve understanding of C. gattii epidemiology. In the present study, we investigated the characterization of C. gattii strains isolated from cryptococcosis patients who had been hospitalized between 1993 and 2010 in Korea.
MATERIALS AND METHODS

Strains and Identification
We examined 125 isolates of C. neoformans isolated from 125 patients admitted to 4 province hospitals over 17 years period. Each isolate was purified by picking up the single colony on Saubouraud dextrose agar plate. The purified colonies were tested for their ability to grow and to grow and produce polysaccharide capsule, melanin, and urease at 37℃.
The biovariety and serotype of each strain was determined using the canavanine-glycine-bromothymol blue agar test analysis (16) . PCR fingerprinting using the minisatellitespecific core sequence of the wild-type phage M13 (5'-GAGGGTGGCGGTTCT-3') was used as a single primer in the PCR. URA5-RFLP analysis was performed using the primers (5'-ATGTCCTCCCAAGCCCTCGACTCCG-3') and (5'-TTAAGACCTCTGAACACCGTACTC-3'), and RFLP profiles were generated after digestion of the PCR product of the URA5 gene sequence with Sau96l and Hhal.
For mating type of C. gattii, we used the mating pheromonespecific primers as described previously (12) .
RESULTS AND DISCUSSION
All three isolates were C. gattii serotype B and mating type MATα. Two patients had underlying conditions, diabetes mellitus and cancer, respectively, and the other had no recognizable predisposing factors for cryptococcosis (Table 1) . The PCR fingerprinting with the minisatellitespecific primer M13 was able to generate individual strain-specific DNA polymorphism, allowing the easy PCR fingerprinting profiles revealed different patterns for C. gattii isolates when compared with reference strains (Fig. 1) . Also the URA5 RFLP confirmed each strain to be VGI (C4), VGIII (C52) and VGII (C89) molecular type, respectively (Fig. 2) . C. gattii strains, 2 were isolated from AIDS patients and 7
were isolated from patients with no apparent risk factors (17) . In the present study, 3 molecular types, VGI, VGIII and VGII were identified from each patient with no underlying disease (C4 strain), hepatoma (C52) and diabetes mellitus (C89), respectively. In Japan, Okamoto (3) reported a case of cerebral cryptococcoma caused by C. gattii VGIIa, which is identical to the Vancouver Island outbreak strain, in a patient who had no recent travel history to known disease-endemic areas. Compared to C. neoformans, less information is known about the epidemiology and ecology of C. gattii, especially molecular types VGIII and VGIV (14) . Accumulating evidence in recent years indicates that C. gattii is also one of the causes of human cryptococcosis 
